CoVIC-154 for COVID-19

 CoVIC-154 has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 200+ treatments. We have not reviewed CoVIC-154 in detail.
Schendel et al., A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein, Cell Reports, doi:10.1016/j.celrep.2025.115499